April 3rd 2025
Researchers reported the case of a 28-year-old woman with epidermodysplasia verruciformis who developed SCC on a sun-protected scalp.
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Treating wild-type BRAF mutated melanoma poses challenges
August 1st 2013Various approaches are being initiated to treat wild-type, BRAF mutated melanoma, according to the director of the Melanoma Program and co-leader of the Signal Transduction Program at Vanderbilt-Ingram Cancer Center in Nashville, Tenn.
Targeted therapy, immunotherapy tackle metastatic melanoma
July 1st 2013There has been a rapid revolution in the treatment of metastatic melanoma since the identification of driver oncogenes such as BRAF and its mutations more than a decade ago, according to a clinical researcher at the Vanderbilt-Ingram Cancer Center, Nashville, Tenn.
Cutting-edge devices evaluate fine nuances of pigmented lesions
June 1st 2013New and cutting edge technologies are proving useful for clinical diagnosis and early detection of melanoma. Depending on the diagnostic tool used, clinicians can improve their assessment of suspicious lesions and better evaluate the fine nuances differentiating benign and malignant pigmented lesions.
Reemergence of targeted photon therapy useful for NMSCs in outpatient setting
May 1st 2013Recent advances in radiation therapy for the treatment of nonmelanoma skin cancer (NMSC) have resulted in a resurgence of targeted photon therapy, a treatment modality particularly useful in an outpatient setting. In carefully selected patients and cases, radiation therapy can often be the treatment of choice for NMSCs, says a clinician who spoke at the annual meeting of the American Academy of Dermatology.
Reformulated drugs for actinic keratosis address issues with field therapy
May 1st 2013New topical agents such as ingenol mebutate (Picato, Leo Pharma), reformulations of standing local treatments as well as combination therapies are not only proving to be very useful in the clearance of actinic keratosis (AK), but they also help address the common issues regarding field therapy.
For some skin cancers, clinicians must consider less expensive options than Mohs surgery
April 1st 2013Although Mohs micrographic surgery represents the gold standard for treatment of many skin cancers, says an expert, healthcare reform dictates that dermatologists also consider less costly options when appropriate.